BioSpace News Archive

Business

23andMe and TrialSpark Announce Joint Clinical Trial Offering and Request For Proposals

23andMe and TrialSpark are announcing a joint clinical trial offering that combines the power of 23andMe’s crowdsourced research platform and extensive database of consenting customers with TrialSpark’s distributed site network and trial services.

September 26, 2019
·
6 min read
Policy

Synthetic Biologics Strengthens U.S. Patent Coverage of SYN-010, Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

Issuance of New Patent and Allowance of Patent Application Diversifies SYN-010 Protection in US

September 26, 2019
·
6 min read
Business

CollPlant Reports Second Quarter 2019 Financial Results and Provides Business Update

CollPlant, a regenerative medicine company, announced financial results for the second quarter ended June 30, 2019 and provided an update on the Company’s business developments.

September 26, 2019
·
11 min read
Business

Sean Doherty Joins Provention Bio Board of Directors

T1D Fund Executive Chairman and Former Bain Capital Managing Director Brings Extensive Financial Expertise and Deep Knowledge of Therapeutics Landscape

September 26, 2019
·
4 min read
Genetown

Verastem Oncology to Present at the Cantor 2019 Global Healthcare Conference

Verastem, Inc. announced that the Company will present at the Cantor 2019 Global Healthcare Conference on Thursday, October 3, 2019 at 8:20 a.m. EDT in New York, NY.

September 26, 2019
·
1 min read
Drug Development

GT Biopharma Announces HIV Trike™ Data to be Published

GT Biopharma, Inc. announced that Dr. Jeffrey Miller and colleagues from the University of Minnesota will present research results concerning an HIV TriKE™ which directs NK cell killing at HIV-infected CD4 T-cells.

September 26, 2019
·
6 min read
Genetown

More and better clinical trial data key to the personalization of treatment decisions for lung cancer patients

MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer

September 26, 2019
·
3 min read
FDA

FDA Approves Abbott’s “Low Dose,” Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain

Abbott announced the U.S. Food and Drug Administration (FDA) has approved the company’s Proclaim XR™ recharge-free neurostimulation system for people living with chronic pain.

September 26, 2019
·
7 min read
BioMidwest

Lands’ End Business Launches Line Of Scrubs For The Healthcare Industry

Lands’ End, the iconic American heritage brand, has launched a new line of scrubs to service the healthcare industry.

September 26, 2019
·
3 min read
Biotech Bay

DURECT to Present at the 2019 Cantor Fitzgerald Global Health Care Conference

DURECT Corporation announced that James E. Brown, Chief Executive Officer will be presenting at the Cantor Fitzgerald Global Health Care Conference, at the InterContinental New York Barclay Hotel on Friday, October 4, 2019 at 10:40 a.m. EDT.

September 26, 2019
·
3 min read